Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1982 to 2031 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1982\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
uv excision repair protein rad23 homolog b (hhr23b) (xp-c repair complementing complex 58 kda protein) (p58). [source:swissprot;acc:p54727]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5475.74\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5800.97\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05939\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1983\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vi. [source:swissprot;acc:q9um54]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1984\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal acyl-coenzyme a thioester hydrolase 2a (ec 3.1.2.2) (peroxisomal long-chain acyl-coa thioesterase 2) (zap128). [source:swissprot;acc:p49753]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5830.03\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6176.1\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05936\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1985\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5516.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.37\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1986\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lap (leucine-rich repeats and pdz) and no pdz protein. [source:refseq;acc:nm\_018214]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5517.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5844.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05935\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1987\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal acyl-coa thioesterase 2b; likely ortholog of mouse peroxisomal acyl-coa thioesterase 2b. [source:refseq;acc:nm\_152331]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5829.74\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6175.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05934\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1988\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3559.49\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3360.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05925\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1989\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
m-phase inducer phosphatase 2 (ec 3.1.3.48) (dual specificity phosphatase cdc25b). [source:swissprot;acc:p30305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4383.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4642.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05922\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1990\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein mrg15 (morf-related gene 15 protein) (mortality factor 4-like 1) (msl3-1 protein) (hspc008/hspc061). [source:swissprot;acc:q9ubu8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5045.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5344.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05914\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1991\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [source:swissprot;acc:q9ugq3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5429.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5749.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05902\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1992\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [source:swissprot;acc:q9ny64]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1993\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin like 1. [source:refseq;acc:nm\_014089]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6174.74\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6538.73\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05895\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1994\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 4 isoform a; apc-stimulated guanine nucleotide exchange factor. [source:refseq;acc:nm\_015320]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1995\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1996\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
survival motor neuron protein (component of gems 1) (gemin1). [source:swissprot;acc:q16637]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5047.2\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5344.68\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05894\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1997\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 1 (p21-rac1) (ras-like protein tc25). [source:swissprot;acc:p15154]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1998\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 3 (p21-rac3). [source:swissprot;acc:o14658]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1999\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin 54kda; nucleoporin p54. [source:refseq;acc:nm\_017426]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2000\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related c3 botulinum toxin substrate 2 (p21-rac2) (small g protein) (gx). [source:swissprot;acc:p15153]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2001\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna replication licensing factor mcm5 (cdc46 homolog) (p1-cdc46). [source:swissprot;acc:p33992]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2002\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
survival of motor neuron protein-interacting protein 1 (smn- interacting protein 1) (component of gems 2) (gemin2). [source:swissprot;acc:o14893]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2003\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
probable atp-dependent rna helicase ddx20 (dead-box protein 20) (dead- box protein dp 103) (component of gems 3) (gemin3). [source:swissprot;acc:q9uhi6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein morf4 (mortality factor 4) (cellular senescence-related protein 1) (sen1). [source:swissprot;acc:q9y690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5047.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5344.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05885\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2005\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-citrate synthase (ec 2.3.3.8) (atp-citrate (pro-s-)-lyase) (citrate cleavage enzyme). [source:swissprot;acc:p53396]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6064.92\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6421.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05882\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2006\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor-like protein mrgx (morf-related gene x protein) (mortality factor 4-like 2) (msl3-2 protein). [source:swissprot;acc:q15014]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5048.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5345.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0588\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2007\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 1 subunit (mu-adaptin 1) (adaptor protein complex ap-1 mu-1 subunit) (golgi adaptor ha1/ap1 adaptin mu-1 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 1) (clathrin coat assembly protein ap47) (clathrin coat associated protein ap47) (ap-mu chain family member mu1a). [source:swissprot;acc:q9bxs5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5684.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6018.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05877\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2008\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40s ribosomal protein s15a. [source:swissprot;acc:p39027]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3637.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3435.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05876\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2009\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
folylpolyglutamate synthase, mitochondrial precursor (ec 6.3.2.17) (folylpoly-gamma-glutamate synthetase) (fpgs). [source:swissprot;acc:q05932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4934.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5223.69\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05861\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2010\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5671.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6003.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05855\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2011\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan synthase 2 (ec 2.4.1.212) (hyaluronate synthase 2) (hyaluronic acid synthase 2) (ha synthase 2). [source:swissprot;acc:q92819]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5391.27\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5706.64\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0585\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2012\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan synthase 1 (ec 2.4.1.212) (hyaluronate synthase 1) (hyaluronic acid synthase 1) (ha synthase 1) (huhas1). [source:swissprot;acc:q92839]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2013\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hyaluronan synthase 3 (ec 2.4.1.212) (hyaluronate synthase 3) (hyaluronic acid synthase 3) (ha synthase 3). [source:swissprot;acc:o00219]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2014\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif3b (microtubule plus end-directed kinesin motor 3b) (hh0048). [source:swissprot;acc:o15066]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5934.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6281.2\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2015\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6555.42\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6938.82\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05849\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2016\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lactoylglutathione lyase (ec 4.4.1.5) (methylglyoxalase) (aldoketomutase) (glyoxalase i) (glx i) (ketone-aldehyde mutase) (s-d-lactoylglutathione methylglyoxal lyase). [source:swissprot;acc:q04760]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2017\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysophospholipase i; lysophospholipase 1; lysophospholipid-specific lysophospholipase; acyl-protein thioesterase-1. [source:refseq;acc:nm\_006330]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2018\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mawd binding protein (unknown protein 32 from 2d-page of liver tissue). [source:swissprot;acc:p30039]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2019\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysophospholipase ii; acyl-protein thioesterase. [source:refseq;acc:nm\_007260]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2020\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
diphthamide biosynthesis-like protein 2. [source:refseq;acc:nm\_001384]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4935.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5224.27\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05844\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2021\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kinesin-like protein kif3c. [source:swissprot;acc:o14782]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5934.68\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6281.49\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2022\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enthoprotin; epsin 4; clathrin interacting protein localized in the trans-golgi region. [source:refseq;acc:nm\_014666]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5520.26\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5841.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05813\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2023\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein translation factor sui1 homolog (sui1iso1). [source:swissprot;acc:p41567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3560.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3364.84\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05807\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2024\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
baculoviral iap repeat-containing protein 5 (apoptosis inhibitor survivin) (apoptosis inhibitor 4). [source:swissprot;acc:o15392]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5976.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6323.87\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2025\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
candidate tumor suppressor in ovarian cancer 2. [source:refseq;acc:nm\_080822]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4813.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5091.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05781\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2026\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
aspartyl-trna synthetase (ec 6.1.1.12) (aspartate--trna ligase) (asprs). [source:swissprot;acc:p14868]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6766.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7155.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0575\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2027\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad9 homolog; cell cycle checkpoint control protein; rad9 homolog (s. pombe). [source:refseq;acc:nm\_004584]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6218.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6575.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05749\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2028\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
54 kda nuclear rna- and dna-binding protein (p54(nrb)) (p54nrb) (55 kda nuclear protein) (nmt55) (non-pou domain-containing octamer- binding protein) (dna-binding p52/p100 complex, 52 kda subunit). [source:swissprot;acc:q15233]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10243.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9686.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05746\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2029\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
paraspeckle protein 1. [source:refseq;acc:nm\_018282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10241.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9685.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05742\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2030\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone-lysine n-methyltransferase, h3 lysine-9 specific 2 (ec 2.1.1.43) (histone h3-k9 methyltransferase 2) (h3-k9-hmtase 2) (suppressor of variegation 3-9 homolog 2) (su(var)3-9 homolog 2). [source:swissprot;acc:q9h5i1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5060.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5350.93\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.05732\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2031\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 2 subunit 1 (eukaryotic translation initiation factor 2 alpha subunit) (eif-2-alpha) (eif- 2alpha) (eif-2a). [source:swissprot;acc:p05198]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/